Dr. Markus Bredel graduated from University Of Vienna Faculty Of Medicine and completed his residency at University of Alabama Medical Center. He also did his fellowship at the Division of Oncology, Stanford University School of Medicine, Palo Alto. He is board certified in the field of oncology and is currently practicing at University of Alabama Hospital. Dr. Bredel has contributed to three research papers.
University of Vienna Faculty of Medicine
University of Alabama Medical Center
Division of Oncology, Stanford University School of Medicine, Palo Alto, CA
American Board of Internal Medicine - Oncology
Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolines.
Anderson, J. C.,Duarte, C. W.,Welaya, K.,Rohrbach, T. D.,Bredel, M.,Yang, E. S.,Choradia, N. V.,Thottassery, J. V.,Yancey Gillespie, G.,Bonner, J. A.,Willey, C. D.; Radiother Oncol. 2014 May 13.See more >>
Targeting Protein Kinase CK2 Suppresses Pro-survival Signaling Pathways and Growth of Glioblastoma.
Zheng, Y.,McFarland, B. C.,Drygin, D.,Yu, H.,Bellis, S. L.,Kim, H.,Bredel, M.,Benveniste, E. N.; Clin. Cancer Res.. 2013 Sep 13.See more >>
Illuminating Radiogenomic Characteristics of Glioblastoma Multiforme through Integration of MR Imaging, Messenger RNA Expression, and DNA Copy Number Variation.
Jamshidi, N.,Diehn, M.,Bredel, M.,Kuo, M. D.; Radiology. 2013 Oct 14.See more >>
American Association for Cancer Research
American Society of Clinical Oncology